Correction
Abstract
In the article "A Controlled Clinical Trial of Alprazolam for the Treatment of Anxiety" by Karl Rickels, M.D., et al. in the January 1983 issue (pp. 82-85), the last complete sentence in column 1 on page 84 should read, "In a second preference rating comparing study drug to prior psychiatric drug, patients on either active drug (alprazolam, 28 of 37 or 76%; diazepam, 20 of 32 or 63%) preferred the study drug more often than did placebo patients (14 of 38 or 37%) (x2=11.99, df=2, p<.01)." The staff regrets this error.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
